Jeffrey S. Wefel

The University of Texas MD Anderson Cancer Center

DentistryEnvironmental Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions”.

Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions

Neuro-Oncology(2024)10.1093/neuonc/noae103

N/A

1.4DataRank · unranked

68 citations

Ugonma Chukwueke, Myung‐Ju Ahn, Ayal A. Aizer, Tejus Bale, Dieta Brandsma +24 more

The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessment

Neuro-Oncology Advances(2021)10.1093/noajnl/vdab035

N/A

0.724DataRank · unranked

14 citations

Quinn T. Ostrom, Shelley M. Pressley, Jennie Taylor, Alissa A. Thomas, Jeffrey S. Wefel +23 more

The National Cancer Institute clinical trials planning meeting to address gaps in observational and intervention trials for cancer-related cognitive impairment

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae209

N/A

0.584DataRank · unranked

15 citations

Kathleen Van Dyk, Sheri J. Hartman, Thuy T. Koll, Christina K. Cramer, Glenn J. Lesser +30 more

Genetic modulation of longitudinal change in neurocognitive function among adult glioma patients

Journal of Neuro-Oncology(2021)10.1007/s11060-021-03905-5

N/A

0.165DataRank · unranked

2 citations

Renke Zhou, Erik P. Sulman, Nicholas S. Boehling, Georgina Armstrong, Spiridon Tsavachidis +8 more

CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design

Neuro-Oncology(2020)10.1093/neuonc/noaa168

N/A

0DataRank · unranked

116 citations

Karla V. Ballman, Martin J. van den Bent, Caterina Giannini, Evanthia Galanis, Paul D. Brown +18 more

Characterization of recurrence patterns and outcomes of medulloblastoma in adults: The University of Texas MD Anderson Cancer Center experience

Neuro-Oncology Advances(2023)10.1093/noajnl/vdad032

N/A

0DataRank · unranked

12 citations

Max Mastall, Heather Lin, Kenneth R. Hess, Ying Yuan, Manuela Martín-Bejarano García +21 more

Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomas

Neuro-Oncology Advances(2023)10.1093/noajnl/vdad087

N/A

0DataRank · unranked

7 citations

M. Kelly Nicholas, Richard A. Peterson, Stefania Maraka, Li Liu, James H. Fischer +10 more

Intraoperative language mapping guided by real-time visualization of gamma band modulation electrocorticograms: Case report and proof of concept

Neuro-Oncology Practice(2023)10.1093/nop/npad059

N/A

0DataRank · unranked

1 citations

Priscella Asman, Israt Tasnim, Matt Hall, Katherine Connelly, Chandra Swamy +12 more

Neurocognitive function outcomes in NRG/RTOG 0534, the SPPORT trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12022

N/A

0DataRank · unranked

0 citations

Theodore Karrison, Alan Pollack, Alexander G. Balogh, Deborah Watkins Bruner, Leonard G. Gomella +14 more

Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial

Neuro-Oncology(2022)10.1093/neuonc/noac173

N/A

0DataRank · unranked

153 citations

Stephanie L. Pugh, Tony J. C. Wang, Kenneth Aldape, Hui Gan, Matthias Preusser +27 more

Alterations in Functional Connectomics Associated With Neurocognitive Changes Following Glioma Resection

Neurosurgery(2020)10.1093/neuros/nyaa453

N/A

0DataRank · unranked

30 citations

Henry Chen, Jeffrey S. Wefel, Vinodh A. Kumar, Ping Hou, Sherise D. Ferguson +7 more

Randomized phase II study of rituximab, methotrexate (MTX), procarbazine, vincristine, and cytarabine (R-MPV-A) with and without low-dose whole-brain radiotherapy (LD-WBRT) for newly diagnosed primary CNS lymphoma (PCNSL).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2501

N/A

0DataRank · unranked

59 citations

Lisa M. DeAngelis, Theodore Karrison, Joe A Bovi, Marc K. Rosenblum, Benjamin W. Corn +16 more

Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience

Neuro-Oncology Advances(2021)10.1093/noajnl/vdab079

N/A

0DataRank · unranked

17 citations

Max Mastall, Heather Lin, Seyede Shiva Dibaj, Kenneth R. Hess, Ying Yuan +21 more